Skip to main content

IBM Announces Definitive Results of Tender Offers for ILOG Following Expiration of the Subsequent Offering Period


ARMONK, NY - 18 Dec 2008: IBM (NYSE:IBM) today announced that the French Autorité des marchés financiers (AMF) published the definitive results of IBM's tender offers in France and the United States for ILOG (NASDAQ: ILOG) (PARIS: ILO) following the expiration of the subsequent offering period. These results indicate that, as of the expiration of the subsequent offering period on December 15, 2008, in aggregate an additional 913,865 ordinary shares (including ordinary shares represented by ADSs) had been tendered into the tender offers.

When combined with the 19,664,945 ordinary shares (including ordinary shares represented by ADSs) tendered into the tender offers during the initial offering period that expired on November 24, 2008, these results indicate that IBM will hold 20,578,810 ordinary shares, representing 96.83 percent of the voting rights and the share capital of ILOG, on an issued and outstanding basis as of December 15, 2008.

Accordingly, IBM will accept all the ordinary shares and ADSs tendered during the subsequent offering period and expects that the settlement of the tender offers and the payment of the cash consideration in respect of the tendered ordinary shares will occur on December 24, 2008.

As the securities not tendered into the tender offers represent less than 5 percent of the voting rights and the share capital of ILOG, IBM requested today the implementation of a squeeze-out of the ordinary shares held by minority shareholders. The AMF is expected to announce the date of the implementation of the squeeze-out on December 19, 2008. The trading of the ordinary shares will be suspended as of December 19, 2008, and the ordinary shares will be delisted from Euronext upon the implementation of the squeeze-out.

As of December 19, 2008, ADSs will be placed on a trading halt. The quotation of ADSs on the NASDAQ Global Select Market will be terminated upon the implementation of the squeeze-out or shortly thereafter. ILOG will terminate the registration of its ordinary shares and ADSs under the U.S. Securities Exchange Act of 1934, as amended, when it becomes eligible to do so.

About IBM
For more information on IBM visit: http://www.ibm.com/soa

Forward-looking Statement
The French Offer and the U.S. Offer (the "Offers") are not being made nor will any tender of securities be accepted from or on behalf of holders in any jurisdiction in which the making of the Offers or the acceptance of any tender of securities therein would not be made in compliance with laws of such jurisdiction.

This press release contains forward-looking statements. These statements are not guarantees of future performance and are subject to inherent risks and uncertainties including with respect to the factors that may affect the completion of the acquisition. Forward-looking statements may be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as "may," "will," "expects," "believes," "anticipates," "plans," "intends," "estimates," "projects," "forecasts," "seeks," "could," "should," or the negative of such terms, and other variations on such terms or comparable terminology.

Forward-looking statements include, but are not limited to, statements about the expected future business of ILOG S.A. resulting from and following the Offers and the successful completion of the transaction. These statements reflect IBM's, CITLOI S.A.S.'s and ILOG S.A.'s managements' current expectations, based upon information currently available to them and are subject to various assumptions, as well as risks and uncertainties that may be outside of their control. Actual results could differ materially from those expressed or implied in such forward-looking statements. Any such forward-looking statements speak only as of the date on which they are made and IBM, CITLOI S.A.S. and ILOG S.A. shall be under no obligation to (and expressly disclaim any such obligation to) update or alter such forward-looking statements whether as a result of a new information, future events or otherwise, except to the extent legally required.

Additional Informatio
This press release is for informational purposes only and is not an offer to buy or a solicitation of an offer to sell any securities of ILOG S.A. The terms and conditions of the U.S. Offer are set forth in the U.S. Offer to Purchase dated October 14, 2008 and the related documentation, as amended, that IBM and its subsidiary, CITLOI S.A.S., filed with the U.S. Securities and Exchange Commission (the "Commission") on Schedule TO and the solicitation/recommendation statement on Schedule 14D-9, as amended, that ILOG S.A. filed with the Commission. The terms and conditions of the French Offer are set forth in the Note d'Information, as amended, that IBM and its subsidiary, CITLOI S.A.S., filed with the French Autorité des marchés financiers (the "AMF") and the Note d'Information en Réponse, as amended, that ILOG S.A. filed with the AMF. The AMF granted its visa on the Note d'Information and the Note d'Information en Réponse on September 12, 2008. CITLOI S.A.S. and ILOG S.A. have also made publicly available documents supplementing the Note d'Information and the Note d' Information en Réponse, respectively, which provide additional legal, financial and accounting information on these entities.

ILOG securityholders and other investors in the U.S. Offer are urged to read carefully the U.S. Offer to Purchase and the related documentation on Schedule TO (as updated and amended) filed by IBM and CITLOI S.A.S. and the solicitation/recommendation statement on Schedule 14D-9 (as updated and amended) filed by ILOG S.A because these documents contain important information. ILOG securityholders and other investors in the French Offer are urged to read carefully the Note d'Information (as updated and amended) filed by IBM and CITLOI S.A.S. and the Note d'Information en Réponse (as updated and amended) filed by ILOG S.A. because these documents contain important information.

ILOG securityholders and other investors can obtain copies of these tender offer materials and any other documents filed with the Commission from the Commission's website (www.sec.gov) and with the AMF from the AMF's website (www.amf-france.org), in both cases without charge. Such materials filed by IBM and CITLOI S.A.S., and ILOG S.A. will also be available for free at IBM's website (www.ibm.com), and at ILOG S.A.'s website (www.ilog.com), respectively.

Questions and requests for assistance may be directed to Georgeson Inc., the information agent (the "Information Agent") (199 Water Street, 26th Floor New York, NY 10038-3650; U.S. Toll Free Number for holders of ILOG securities in the United States: (800) 334-9405; U.S. Number for banks and brokers: (212) 440-9800; European Toll Free Number: 00800 10 20 10 80) or UBS Securities LLC, the dealer manager for the U.S. Offer (the "Dealer Manager") (1999 Avenue of the Stars, Suite 3400, Los Angeles, California 90067; (877) 566-3332). You may also contact your broker, dealer, commercial bank, trust company or other nominee for assistance concerning the U.S. Offer. None of IBM or CITLOI S.A.S. will pay any fees or commissions to any broker or dealer or any other person (other than the Information Agent and the Dealer Manager) for soliciting tenders of ILOG securities pursuant to the U.S. Offer.

ILOG securityholders and other investors are urged to read carefully all tender offer materials prior to making any decisions with respect to the Offers.

Contact(s) information

Chris Rubsamen
IBM Media Relations
914-766-1803
rubsamen@us.ibm.com

Related XML feeds
Topics XML feeds
Corporate
Financial news, company earnings, philanthropy, community service, human resources, sponsorship
Software
Information Management, Lotus, Tivoli, Rational, WebSphere, Open standards, open source

Document options